—
C+
C+ The full Closelook — membership. Open the C+ overview

Summit Therapeutics PLC (SMMT) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +21.7% vs the 50-day and +8.6% vs the 200-day average, 38.9% below the 52-week high and +47.9% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the SMMT chart & overview · the earnings record · the signal board

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on SMMT?

Recovery attempt under the 200-day — Trades +21.7% vs the 50-day and +8.6% vs the 200-day average, 38.9% below the 52-week high and +47.9% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SMMT above its 50-day and 200-day moving averages?

As of 2026-09-18, Summit Therapeutics PLC trades +21.7% above its 50-day and +8.6% above its 200-day average, with the 20-day +12.7% away.

How far is SMMT from its 52-week high?

38.9% below the 52-week high and 47.9% above the 52-week low, as of 2026-09-18.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.